| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.39 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |